# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-23-085198
Filing Date
2023-11-09
Accepted
2023-11-09 16:01:22
Documents
3
Period of Report
2023-11-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PROXY STATEMENT | pre14a1123_jasperthera.htm | PRE 14A | 458824
2 | GRAPHIC | tproxy_001.jpg | GRAPHIC | 1388488
3 | GRAPHIC | tproxy_002.jpg | GRAPHIC | 1032599
| Complete submission text file | 0001213900-23-085198.txt |  | 3795227

Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Filer) CIK: 0001788028 (see all company filings)

EIN.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39138 | Film No.: 231392142
SIC: 2836 Biological Products, (No Diagnostic Substances)